James Rogers III, J.D.
Chair, Department of Business Development
Jim Rogers serves as Chair of Mayo Clinic’s newly formed Department of Business Development, which merged Mayo Clinic Ventures and the Office of Business Development. Jim is the immediate past Chair of Mayo Clinic Ventures and past Deputy Director of the Center for Regenerative Medicine. Mr. Rogers serves on the Mayo Clinic Administrative Team, Management Team and the investment committee of Mayo’s $100 million Venture and Growth Fund. Mr. Rogers also serves on several external boards including: Medical Alley Association, Rochester Area Economic Development, Lourdes Foundation, Resoundant, Inc., and the Merchants Bank Local Advisory. Mr. Rogers is a licensed patent attorney and has more than 20 years of experience in intellectual property and commercialization of technologies, including serving for more than a decade in the Legal Department at Mayo Clinic. Before coming to Mayo, Mr. Rogers worked at Dorsey & Whitney, LLP, and 3M Company. Mr. Rogers is a graduate of the University of Iowa and University of Iowa College of Law, where he earned his B.S. in biology and his J.D. with high distinction.
Vice Chair, Licensing
Andy Danielsen has been with Mayo Clinic Ventures since 2002. He oversees the licensing, technology development, and business development functions of the office. Collectively, these groups work to identify, develop, and commercialize Mayo Clinic intellectual property. Prior to joining the office, Danielsen conducted research at Mayo Clinic where he worked to identify therapeutic targets in breast and ovarian cancer. He received a B.S. in biochemistry and molecular biology from the University of Wisconsin-Eau Claire, his M.S. degree in molecular biology from the Mayo Graduate School of Medicine, and is a registered Patent Agent.
Senior Manager | Devices, Diagnostics
Kelly Krajnik has been with Mayo Clinic Ventures since 2006. Prior to joining MCV, she worked at Mayo Clinic as a senior research technologist in the microarray core facility, was a member of the Institutional Review Board and worked in the Department of Laboratory Medicine and Pathology to develop new molecular diagnostic assays. Krajnik received a B.S. in microbiology from the University of Wisconsin-La Crosse and an M.B.A. from University of St. Thomas. She is also a registered patent agent.
Senior Manager | Healthcare IT
Timmeko Love joined Mayo Clinic Ventures in 2014. Previously, she was a principal at Best Buy Capital, where she led direct investments in consumer technology startups. Prior to Best Buy, she worked in the semiconductor industry in business development, product management, product marketing and R&D engineering roles. Love received an M.B.A. from Columbia Business School, an M.S. in engineering physics from Cornell University and joint B.S. degrees in physics from Dartmouth College and Florida A&M University.
Manager | Cardiology
Gaurav Satam joined Mayo Clinic Ventures in 2015. Prior to joining MCV, Gaurav worked at Inovalon, a healthcare data analytics company and at St Jude Medical Cardiovascular division. During his career in the healthcare industry, he worked in R&D, strategic development, finance, and product management roles. Mr. Satam received his M.B.A. from Carlson School of Management, University of Minnesota, Twin Cities, M.S. in Mechanical Engineering from California State University, Long Beach and B.E. in Mechanical Engineering from University of Mumbai, India.
Director | Devices, Diagnostics, Cardiology
Tim Argo, CLP, joined Mayo Clinic in 1996. Prior to moving to Rochester, he was a licensing associate with Kansas State University Research Foundation and a sales representative for a major pharmaceutical company. Argo received both a B.S. in microbiology and an M.B.A. in finance from Kansas State University.
Senior Manager | Healthcare IT, Diagnostics
Pete Ball joined Mayo Clinic Ventures in 2016. His prior experience includes being portfolio director at Johns Hopkins Technology Ventures where he facilitated business development, corporate partnerships, commercialization and startup company activities. He holds a B.A. degree in Psychobiology from Hamilton College, an M.S. degree in Operations Research from Columbia University, a J.D. degree from the University of Baltimore.
Manager | Biopharma, Diagnostics, Orthopedics
Jon Behringer joined Mayo Clinic Ventures in 2016. Prior to joining MCV, he held various roles in food manufacturing and clinical diagnostic testing. He received his B.S. degree in Biology with a concentration in Biomedical Science from the University of Wisconsin - La Crosse and his M.S. degree in Biotechnology from the University of Wisconsin - Madison.
Darren Carney, Ph.D.
Senior Manager | Cardiology, Orthopedics
Darren Carney joined Mayo Clinic Ventures in 2008. Prior to joining MCV, he spent six years performing research at Mayo in the Department of Biochemistry and Molecular Biology. He received his B.S. in biology and biochemistry from Trinity University and his Ph.D. in biological chemistry from UT Southwestern.
Associate | Cardiology, Devices, Radiology, Research Tools
Matt Ennis joined Mayo Clinic Ventures in 2016. Matt received a B.S. in Biotechnology from North Dakota State University, a Master’s Degree in Biomedical Sciences Biochemistry from Mayo Clinic College of Medicine, and an MBA from Augsburg University.
Senior Manager | Radiology, Healthcare IT
Barb Keller joined Mayo Clinic in 2002. She received a B.S. in paralegal studies from Winona State University with a minor in sociology and an M.A. in both health and human services administration and management from Saint Mary’s University. Prior to MCV, she worked as a contract manager within Mayo Clinic Legal Contract Administration. She also has been a patent analyst at IBM.
Manager | Biopharma, Devices
Susan Mikell joined Mayo Clinic Ventures in 2014. Prior to this role, Susan was a Program Coordinator within Mayo’s Cardiovascular Research department. She received her Bachelor of Arts degree in English from the University of Texas – Austin.
Leif Nelson joined Mayo Clinic Ventures in 2000 and manages a diverse portfolio of technologies. He has facilitated and negotiated sponsored research, collaboration and license agreements with pharmaceutical, diagnostic, medical device and startup companies. After graduating from Winona State University, he began his career at Mayo Clinic in the ophthalmology research laboratory in 1984.
Manager | Diagnostics, Healthcare IT
Reeghan Raffals joined Mayo Clinic Ventures in 2017. Before joining MCV, he practiced law in Boston and Chicago for fifteen years as both a partner and associate, specializing in complex commercial litigation. Reeghan received his law degree from Harvard Law School. He also received an A.B. in Fundamentals: Issues and Texts and an A.M. and Ph.D. from the Committee on Social Thought at the University of Chicago.
Senior Manager | Biopharma
Panya Taysavang joined Mayo Clinic Ventures in 2016. Prior to joining MCV, he held the position of senior licensing associate at Emory University’s Office of Technology Transfer. Prior to his technology transfer role, Panya spent eleven years as a Lead Research Specialist for Emory’s School of Medicine. He holds a B.A. in Chemistry and Philosophy from Emory University and an M.B.A. from the Robinson College of Business at Georgia State University.